---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-029361"
form_type: "8-K"
ticker: "PASG"
cik: "0001787297"
company_name: "Passage BIO, Inc."
filed_at: "2024-02-29T23:59:59+00:00"
generated_at: "2026-06-05T07:10:41.307987+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Passage Bio regains Nasdaq minimum bid price compliance

## Summary
- Received notice from Nasdaq on Feb 29, 2024 confirming compliance with Listing Rule 5450(a)(1).
- Closing bid price of common stock was at least $1.00 for 10 consecutive business days through Feb 28.
- Previously disclosed deficiency notice on Aug 31, 2023 for bid price below $1.00 for 30 days.
- Listing matter is now closed; company meets all other continued listing criteria.

## SEC filing metadata
- accession: 0001104659-24-029361
- form_type: 8-K
- ticker: PASG
- cik: 0001787297
- company_name: Passage BIO, Inc.
- filed_at: 2024-02-29T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787297/000110465924029361/0001104659-24-029361-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787297/000110465924029361/tm247492d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-029361
- JSON: https://secwatch.observer/filing/0001104659-24-029361.json
- Plain text: https://secwatch.observer/filing/0001104659-24-029361.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.